Related Experiment Videos
Genetic variants predisposing to cardiovascular disease
Sophie Visvikis-Siest1, Jean-Brice Marteau
1INSERM U525 Equipe 4, Faculty of Pharmacy, Nancy, France. sophie.visvikis-siest@nancy.inserm.fr
Current Opinion in Lipidology
|March 15, 2006
Summary
Recent research identifies new genes linked to cardiovascular disease (CVD) risk, but replication issues hinder breakthroughs. Understanding gene-environment interactions is crucial for predicting individual CVD predisposition.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Complex Disorders
Background:
- Cardiovascular diseases (CVD) are complex disorders influenced by multiple genetic and environmental factors.
- Understanding genotype-phenotype associations is key to unraveling CVD predisposition.
Purpose of the Study:
- To review recent findings on genetic factors associated with cardiovascular disease risk markers and events.
- To highlight methodological challenges in studying the genetics of complex disorders like CVD.
- To emphasize the role of gene-environment interactions in CVD predisposition.
Main Methods:
- Review of recent literature on genotype-phenotype associations in cardiovascular disease.
- Analysis of candidate genes and novel loci implicated in CVD predisposition.
- Examination of gene-environment interactions in the context of complex disorders.
Main Results:
- Identification of traditional candidate genes (e.g., ACE, MTHFR) and newly discovered loci (e.g., MEF2A, APOM) associated with CVD.
- Genes at the intersection of age-related disorders and CVD (e.g., APOA5, PPARgamma) were examined.
- Significant progress in understanding the complexity of CVD genetics and gene-environment interactions.
Conclusions:
- Despite efforts, major breakthroughs in CVD genetics are limited by poor result replication due to experimental design flaws.
- Gene-environment interactions are critical drivers of individual CVD predisposition.
- Future genetic studies must incorporate high-quality environmental data to assess the clinical utility of genetic risk predictors.